Miller Ann Calby 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed May 17, 2021
Insider Transaction Report
Form 4
Miller Ann Calby
Director
Transactions
- Exercise/Conversion
Common Stock
2021-05-14+8,700→ 25,261 total - Award
Restricted Stock Unit
2021-05-13+18,000→ 18,000 total→ Common Stock (18,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2021-05-14−8,700→ 0 total→ Common Stock (8,700 underlying) - Award
Common Stock Options
2021-05-13+27,000→ 27,000 totalExercise: $6.23Exp: 2031-05-13→ Common Stock (27,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.
- [F2]This grant was made pursuant to the issuer's non-employee director compensation policy.
- [F3]Options to vest 100% on May 13, 2022.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.